ERMISCH PROBE 2.0

Treatment with the ERMISCHE PROBE 2.0 is essential for patients suffering from an acute small bowel obstruction. Without targeted Ermisch probe treatment, patients are at significant risk of life-threatening health issues, such as strangulation, perforation of the gut and sepsis. These complications can result in a significant worsening of quality of life and pose an increased risk of mortality.

By using the Ermisch probe, practitioners can decompress the small intestine quickly and effectively. This significantly reduces the risk of the complications described above and in many cases can help prevent the need for invasive surgeries. Therapy using the Ermisch probe has consequently proven to be a life-saving procedure that not only ensures the immediate survival of patients, but also minimises the long-term damage to their health.

The critical condition of patients with an acute small bowel obstruction can be documented through objectifiable findings such as X-rays, CT scans and clinical symptoms like pain, vomiting and distension of the abdomen. While specific scoring systems do exist for assessing the degree of severity of a bowel obstruction, use of the Ermisch probe is an intra-operative decision only which is always determined by the extent of the obstruction diagnosed and the expertise of the surgeon.

Overall, therapy with the ERMISCH PROBE 2.0 can significantly reduce health risks and mortality rate among patients with a small bowel obstruction and makes a vital difference to improving quality of life.